Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Allscripts Healthcare Solutions Inc (MDRX): Healthcor Management LP Cuts Stake To 4.0%

Healthcor Management LP, managed by Arthur B Cohen and Joseph Healey, has cut its activist stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to 4.0% from 5.6%. A newly amended filing with the U.S. Securities and Exchange Commission revealed that Healthcor holds 7.21 million shares of the company’s common stock, down from around 10 million shares the fund held previously.

Arthur B Cohen and Joseph Healey

Healthcor Management filed a lawsuit in May 2012 against Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) in Delaware’s Court of Chancery. The hedge fund criticized termination of Chairman Phil Pead, and opposed an extension of the nomination deadline, as well as a delay of the company’s annual meeting. Following Pead’s removal, three other members also resigned from the company’s board. Later, Healthcor Management withdrew its suit after Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) agreed on the nomination of three independent directors to the board.

In April 2012, Healthcor Management demanded the company’s CEO Glen Tullman to step down, and requested the company’s board to take the proper actions in the interest of shareholder value, including “putting the company up for sale.”

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) reported strong results for the second quarter of 2014. For the first time in more than two years, the company’s bookings, revenue and adjusted EBITDA all grew year-over-year, according to a statement.

For the quarter, Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) posted a 2% increase in total revenue to $354 million, compared with $347 in the same quarter of 2013. Its second quarter 2014 non-GAAP net income was $16 million, up from $9 million in the same period a year ago. The company’s second quarter 2014 non-GAAP earnings per share were $0.09, compared with $0.05 in the second quarter of 2013.

For the company’s stock, analysts have the consensus average recommendation of ‘Overweight,’ with the consensus average target price $18.70.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) is engaged in providing healthcare information technology solutions that advance clinical, financial and operational results. The company has a market cap of more than $2 billion. Since September 2012, the company’s stock performed well, showing more than 25% growth.

Other investors that are bullish on Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) include Eminence Capital, led by Ricky Sandler, which owns 9.25 million shares, and Clifton S. Robbins’ Blue Harbour Group, which holds 8.94 million shares of the company.

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.